Clinical and Cost Effectiveness of Bevacizumab + FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea by Lee, Eui-Kyung, PhD, Revil, Cedric, MSc, Ngoh, Charles A., MSc, Lister, Johanna, MSc, Kwon, Jeong-Mi, MSc, Park, Mee-Hye, PhD, Park, Seok-Jin, MSc, Park, Young-Suk, PhD, MD, Shin, Sang-Joon, PhD, MD, Lee, Myung-Ah, PhD, MD, Lee, Nam-Su, PhD, MD, Zang, Dae-Young, PhD, MD, Bae, Eun-Jin, MSc, Kang, Mi-Jeong, BSc

Get full text